Respiratory infection due to COVID-19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: standard treatment associated with High-power laser (lumix® 3 model manufactured by Italian physioline company) for 5 sessions every other day with C.P.S anti-infla
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Positive PCR test The ratio below 300 mm Hg for the pressure of oxygen (Pao2) to the inspired oxygen (Fio2) Hospitalized in the internal or special ward of the hospital Severe pulmonary involvement based on CT scan Severe stage of the disease
Exclusion criteria
Exclusion criteria: Intubation of the patient Ratio more than 300 mm Hg Mild to moderate severity of the disease Diseases such as lung and spinal cancer, heart disease, high high blood pressure and any conditions that are contraindicated for laser therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pneumonia severity indices. Timepoint: Before and after the study. Method of measurement: Pulmonary CT-scan.;Laboratory tests. Timepoint: Before and after the study. Method of measurement: Inflammatory factors such as Interleukin-6, ferritin, C-reactive protein, Erythrocyte sedimentation rate and blood factors. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Rasool Bagheri
Semnan University of Medical Sciences
Outcome results
None listed